MedPath

Bone Quality Lyon Orleans

Active, not recruiting
Conditions
Osteopenic Women
Registration Number
NCT01150032
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

QUALYOR is a prospective study on the predictive value for fragility fracture of various new techniques assessing bone quality, among postmenopausal women with low bone mass.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
1605
Inclusion Criteria
  • 50 or older women
  • post-menopausal since at least one year
  • with osteopenia (T-score between -1.0 and -2.5 (with clinical factor risk) or -3.0 (without clinical factor risk)
Exclusion Criteria
  • corticosteroid therapy > 3 months, at least 7.5mg/day equivalent prednisolon (stopped since at least 1 year)
  • osteoporosis treatment antecedent
  • fragility fracture antecedent
  • on going post-menopausal hormonal treatment
  • clinical signs of hepatic, cardiac or respiratory insufficiency, diseases possibly affecting bone metabolism
  • life expectancy < 4 years, mental or serious illness

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fragility fracture4 years

Appearance of vertebral or non-vertebral fracture during the 4 years follow-up

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Hospices Civils de Lyon

🇫🇷

Lyon, France

Centre Hospitalier d'Orléans

🇫🇷

Orléans, France

Hospices Civils de Lyon
🇫🇷Lyon, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.